- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1534-4681
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
KRAS Mutation in Colon Cancer: A Marker of Resistance to EGFR-I Therapy ; volume:17 ; number:4 ; day:20 ; month:11 ; year:2009 ; pages:1168-1176 ; date:4.2010
Annals of surgical oncology ; 17, Heft 4 (20.11.2009), 1168-1176, 4.2010
- Creator
-
Siddiqui, Ahmad D.
Piperdi, Bilal
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1245/s10434-009-0811-z
- URN
-
urn:nbn:de:101:1-2019100804242644552402
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:38 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Siddiqui, Ahmad D.
- Piperdi, Bilal
- SpringerLink (Online service)
Other Objects (12)
Inzidenz von somatischen onkogenen EGFR-, HRAS- und KRAS-Mutationen in seborrhoischen Keratosen
AMPK activation overcomes anti-EGFR antibody resistance induced by KRAS mutation in colorectal cancer
Pyrosequencing data analysis software: a useful tool for EGFR, KRAS, and BRAF mutation analysis
Colorectal cancer with KRAS mutation
High frequency of KRAS and EGFR mutation profiles in BRAF-negative thyroid carcinomas in Indonesia
Concordance of KRAS/BRAF Mutation Status in Metastatic Colorectal Cancer before and after Anti-EGFR Therapy
Klonale Dynamik unter dem selektiven Druck einer Epidermal Growth Factor Receptor (EGFR)-gerichteten Therapie am Beispiel von EGFR-Ektodomänen-Mutationen und KRAS
Detektion von KRAS-Gen-Mutationen beim Bronchialkarzinom
Short report: Performance evaluation of the Idylla™ KRAS and EGFR mutation tests on paraffin-embedded cytological NSCLC samples
The prognostic values of EGFR expression and KRAS mutation in patients with synchronous or metachronous metastatic colorectal cancer
Einfluss der K-RAS Mutation auf die Wirksamkeit einer EGFR-Inhibition in Kombination mit fraktionierter Strahlentherapie in humanem Tumorxenograft
High resolution melting analysis for rapid and sensitive EGFR and KRAS mutation detection in formalin fixed paraffin embedded biopsies
Inzidenz von somatischen onkogenen EGFR-, HRAS- und KRAS-Mutationen in seborrhoischen Keratosen
AMPK activation overcomes anti-EGFR antibody resistance induced by KRAS mutation in colorectal cancer
Pyrosequencing data analysis software: a useful tool for EGFR, KRAS, and BRAF mutation analysis
Colorectal cancer with KRAS mutation
High frequency of KRAS and EGFR mutation profiles in BRAF-negative thyroid carcinomas in Indonesia
Concordance of KRAS/BRAF Mutation Status in Metastatic Colorectal Cancer before and after Anti-EGFR Therapy
Klonale Dynamik unter dem selektiven Druck einer Epidermal Growth Factor Receptor (EGFR)-gerichteten Therapie am Beispiel von EGFR-Ektodomänen-Mutationen und KRAS
Detektion von KRAS-Gen-Mutationen beim Bronchialkarzinom
Short report: Performance evaluation of the Idylla™ KRAS and EGFR mutation tests on paraffin-embedded cytological NSCLC samples
The prognostic values of EGFR expression and KRAS mutation in patients with synchronous or metachronous metastatic colorectal cancer
Einfluss der K-RAS Mutation auf die Wirksamkeit einer EGFR-Inhibition in Kombination mit fraktionierter Strahlentherapie in humanem Tumorxenograft
High resolution melting analysis for rapid and sensitive EGFR and KRAS mutation detection in formalin fixed paraffin embedded biopsies
Inzidenz von somatischen onkogenen EGFR-, HRAS- und KRAS-Mutationen in seborrhoischen Keratosen
AMPK activation overcomes anti-EGFR antibody resistance induced by KRAS mutation in colorectal cancer
Pyrosequencing data analysis software: a useful tool for EGFR, KRAS, and BRAF mutation analysis
Colorectal cancer with KRAS mutation
High frequency of KRAS and EGFR mutation profiles in BRAF-negative thyroid carcinomas in Indonesia
Concordance of KRAS/BRAF Mutation Status in Metastatic Colorectal Cancer before and after Anti-EGFR Therapy
Klonale Dynamik unter dem selektiven Druck einer Epidermal Growth Factor Receptor (EGFR)-gerichteten Therapie am Beispiel von EGFR-Ektodomänen-Mutationen und KRAS
Detektion von KRAS-Gen-Mutationen beim Bronchialkarzinom
Short report: Performance evaluation of the Idylla™ KRAS and EGFR mutation tests on paraffin-embedded cytological NSCLC samples
The prognostic values of EGFR expression and KRAS mutation in patients with synchronous or metachronous metastatic colorectal cancer
Einfluss der K-RAS Mutation auf die Wirksamkeit einer EGFR-Inhibition in Kombination mit fraktionierter Strahlentherapie in humanem Tumorxenograft